Metraipolis › archive › dc_a69a9dd710d1

Halogenated anthraquinones in breast cancer therapy: Structural modifications targeting VEGF-related angiogenesis pathways — Europe PMC PMID:42389487

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42389487
DOI
10.1016/j.jpha.2025.101538
License (as archived)
solo-consultazione
Archived
2026-11-06T23:10:58.671Z
SHA-256 of the archived text
34c642b2fcbc42659439c84856df86a3b5f8569d7e0bc72a616c3c9131e98f99
Stable URL of this page
https://metraipolis.com/documento/dc_a69a9dd710d1

How to cite

Halogenated anthraquinones in breast cancer therapy: Structural modifications targeting VEGF-related angiogenesis pathways — Europe PMC PMID:42389487 — Europe PMC (en), https://europepmc.org/article/MED/42389487 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a69a9dd710d1 (Metraipolis archive dc_a69a9dd710d1, sha256 34c642b2fcbc42659439c84856df86a3b5f8569d7e0bc72a616c3c9131e98f99)
BibTeX
@misc{dca69a9dd710d1,
  title = {Halogenated anthraquinones in breast cancer therapy: Structural modifications targeting VEGF-related angiogenesis pathways — Europe PMC PMID:42389487},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42389487},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a69a9dd710d1; sha256 34c642b2fcbc42659439c84856df86a3b5f8569d7e0bc72a616c3c9131e98f99},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42389487. Agents can read the archived copy with the MCP tool read_document.